Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
676.77
+7.57 (1.13%)
At close: Oct 26, 2026, 4:00 PM EDT
679.99
+3.22 (0.48%)
Pre-market: Oct 27, 2026, 7:20 AM EDT
Medpace Holdings Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 716 | 707.33 | 706.6 | 708.45 | 659.9 | 603.31 | 558.57 | 536.59 | 533.32 | 528.1 | 511.04 | 498.4 | 492.5 | 460.87 | 434.07 | 394.1 | 383.74 | 351.21 | 330.95 | 308.55 |
Revenue Growth | 8.50% | 17.24% | 26.50% | 32.03% | 23.74% | 14.24% | 9.30% | 7.66% | 8.29% | 14.59% | 17.73% | 26.47% | 28.34% | 31.22% | 31.16% | 27.73% | 29.83% | 26.20% | 27.30% | 18.82% |
Gross Profit Gross Profit Growth | 511.15 | 504.78 | 508.33 | 526.3 | 473.57 | 417.49 | 380.75 | 369.07 | 361.78 | 356.56 | 339.55 | 334.11 | 328.14 | 302.34 | 283.01 | 253.41 | 247.1 | 219.09 | 205.51 | 189.62 |
Operating Income Operating Income Growth | 165.54 | 146.82 | 141.5 | 153.27 | 141.81 | 126.34 | 113.52 | 125.38 | 112.27 | 105.15 | 104.07 | 87.32 | 84.91 | 78.39 | 86.2 | 76.43 | 77.83 | 60.24 | 64.2 | 54.86 |
Net Income Net Income Growth | 137.46 | 121.36 | 123.87 | 135.13 | 111.14 | 90.26 | 114.6 | 116.93 | 96.43 | 88.35 | 102.55 | 78.25 | 70.5 | 61.03 | 72.85 | 68.63 | 65.98 | 49.33 | 61.28 | 50 |
Earnings Per Share EPS Growth | 4.84 | 4.25 | 4.28 | 4.66 | 3.86 | 3.10 | 3.67 | 3.67 | 3.01 | 2.75 | 3.20 | 2.46 | 2.22 | 1.93 | 2.27 | 2.11 | 2.05 | 1.46 | 1.69 | 1.32 |
EPS Growth | 25.39% | 37.10% | 16.62% | 26.94% | 28.24% | 12.73% | 14.69% | 49.22% | 35.59% | 42.49% | 40.97% | 16.52% | 8.29% | 32.19% | 34.32% | 59.61% | 58.91% | 37.74% | 48.25% | -1.34% |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Metabolic Metabolic Growth | 209.24 | 219.07 | 237.56 | 249.81 | 199.26 | 147.87 | 148.02 | 122.87 | 124.73 | 106.3 | 103.64 | 99.02 | 103.12 | 87.86 | 86.84 | 77.49 | 63.48 | 55.6 | 48.12 | 47.13 |
Oncology Oncology Growth | 229.93 | 209.37 | 201.24 | 195.92 | 192.64 | 188.56 | 170.48 | 168.17 | 164.92 | 162.95 | 155.2 | 148.73 | 149.33 | 147.09 | 141.95 | 124.21 | 122.83 | 115.54 | 105.21 | 95.74 |
Other Sources Other Sources Growth | 99.96 | 98.28 | 93.32 | 88.25 | 106.4 | 118.06 | 95.84 | 103.18 | 107.37 | 112.43 | 108.4 | 110.53 | 106.16 | 101.06 | 87.1 | 80.18 | 72.77 | 73.56 | 70.42 | 70.27 |
Central Nervous System Central Nervous System Growth | 83.65 | 82.86 | 80.21 | 73.18 | 65.63 | 61.13 | 54.9 | 49.22 | 42.1 | 46.52 | 44.14 | 39.65 | 43.99 | 37.73 | 38.7 | 37.13 | 43.42 | 38.91 | 38.49 | 35.33 |
Cardiology Cardiology Growth | 61.41 | 59.98 | 56.26 | 63.04 | 59.47 | 58.58 | 58.28 | 58.3 | 55.81 | 60.7 | 55.64 | 51.58 | 44.36 | 51.13 | 46.62 | 45.41 | 49.8 | 42.03 | 37.4 | 33.15 |
AVAI AVAI Growth | 31.82 | 37.77 | 38.02 | 38.25 | 36.52 | 29.11 | 31.06 | 34.84 | 38.38 | 39.2 | 44.03 | 48.89 | 45.55 | 36.01 | 32.87 | 29.69 | 31.45 | 25.58 | 31.32 | 26.93 |
Revenue (Total) Revenue (Total) Growth | 716 | 707.33 | 706.6 | 708.45 | 659.9 | 603.31 | 558.57 | 536.59 | 533.32 | 528.1 | 511.04 | 498.4 | 492.5 | 460.87 | 434.07 | 394.1 | 383.74 | 351.21 | 330.95 | 308.55 |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 705.32 | 502.69 | 652.68 | 497.05 | 285.35 | 46.33 | 441.44 | 669.44 | 656.9 | 510.89 | 407.01 | 245.45 | 95.21 | 39.14 | 46.92 | 28.27 | 31.01 | 42.55 | 82.84 | 461.3 |
Total Debt Total Debt Growth | 171.46 | 144.11 | 146.09 | 136.85 | 143.97 | 149.83 | 150.35 | 149.52 | 151.89 | 153.73 | 158.13 | 164.49 | 163.32 | 214.38 | 276.93 | 208.14 | 297.59 | 403.45 | 160.08 | 147.24 |
Net Cash (Debt) Net Cash Growth | 533.86 | 358.58 | 506.59 | 360.2 | 141.38 | -103.5 | 291.09 | 519.91 | 505.01 | 357.17 | 248.88 | 80.96 | -68.11 | -175.24 | -230.01 | -179.87 | -266.59 | -360.9 | -77.24 | 314.06 |
Net Cash Growth | 277.61% | - | 74.03% | -30.72% | -72.00% | - | 16.96% | 542.17% | - | - | - | - | - | - | - | - | - | - | - | 114.04% |
Net Cash Per Share Net Cash Per Share Growth | 18.82 | 12.56 | 17.49 | 12.44 | 4.91 | -3.55 | 9.33 | 16.31 | 15.74 | 11.13 | 7.78 | 2.54 | -2.14 | -5.55 | -7.15 | -5.55 | -8.27 | -10.71 | -2.12 | 8.32 |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 216.6 | 162.01 | 151.79 | 192.65 | 246.21 | 148.53 | 125.84 | 190.67 | 149.08 | 116.4 | 152.68 | 156.4 | 114.39 | 82.52 | 80.08 | 136.68 | 108.49 | 96.62 | 46.26 | 70.89 |
Capital Expenditures CapEx Growth | -20.16 | -23.91 | -6.81 | -4.54 | -10.71 | -6.11 | -9.99 | -7.64 | -10.54 | -12.87 | -5.5 | -9.99 | -8.7 | -8.45 | -9.51 | -9.24 | -7.18 | -11.2 | -9.26 | -9.12 |
Free Cash Flow Free Cash Flow Growth | 196.44 | 138.1 | 144.97 | 188.12 | 235.5 | 142.41 | 115.84 | 183.02 | 138.54 | 103.53 | 147.18 | 146.41 | 105.68 | 74.07 | 70.56 | 127.44 | 101.31 | 85.42 | 37 | 61.78 |
Free Cash Flow Growth | -16.59% | -3.03% | 25.15% | 2.78% | 69.99% | 37.56% | -21.29% | 25.01% | 31.09% | 39.76% | 108.58% | 14.88% | 4.31% | -13.28% | 90.72% | 106.29% | 54.17% | 50.51% | -27.18% | -36.78% |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.39% | 71.36% | 71.94% | 74.29% | 71.76% | 69.20% | 68.17% | 68.78% | 67.84% | 67.52% | 66.44% | 67.04% | 66.63% | 65.60% | 65.20% | 64.30% | 64.39% | 62.38% | 62.10% | 61.46% |
Operating Margin | 23.12% | 20.76% | 20.03% | 21.63% | 21.49% | 20.94% | 20.32% | 23.37% | 21.05% | 19.91% | 20.36% | 17.52% | 17.24% | 17.01% | 19.86% | 19.39% | 20.28% | 17.15% | 19.40% | 17.78% |
Pretax Margin | 23.87% | 21.44% | 20.89% | 22.14% | 21.64% | 20.64% | 21.16% | 24.95% | 22.27% | 20.92% | 22.07% | 18.20% | 16.89% | 16.44% | 19.82% | 18.69% | 21.34% | 17.65% | 19.74% | 18.12% |
Profit Margin | 19.20% | 17.16% | 17.53% | 19.07% | 16.84% | 14.96% | 20.52% | 21.79% | 18.08% | 16.73% | 20.07% | 15.70% | 14.31% | 13.24% | 16.78% | 17.41% | 17.20% | 14.05% | 18.52% | 16.20% |
FCF Margin | 27.43% | 19.52% | 20.52% | 26.55% | 35.69% | 23.61% | 20.74% | 34.11% | 25.98% | 19.60% | 28.80% | 29.38% | 21.46% | 16.07% | 16.26% | 32.34% | 26.40% | 24.32% | 11.18% | 20.02% |
Fiscal Quarter | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 33.64 | 30.77 | 29.60 | 35.07 | 33.37 | 21.57 | 22.30 | 25.54 | 28.31 | 37.57 | 39.80 | 33.28 | 27.11 | 27.28 | 22.74 | 26.94 | 21.50 | 22.96 | 27.65 | 43.12 |
Forward PE | 34.10 | 30.58 | 28.06 | 33.86 | 34.63 | 25.78 | 24.66 | 27.33 | 27.99 | 36.40 | 38.40 | 31.74 | 27.08 | 28.49 | 23.16 | 27.33 | 25.04 | 23.35 | 27.95 | 42.23 |
P/FCF Ratio | 26.10 | 21.40 | 19.17 | 23.20 | 21.34 | 15.56 | 17.16 | 18.04 | 19.32 | 25.38 | 26.26 | 23.71 | 19.59 | 19.62 | 15.18 | 18.81 | 17.07 | 19.20 | 24.94 | 33.28 |
PS Ratio | 6.14 | 5.44 | 5.09 | 6.25 | 6.13 | 4.04 | 4.30 | 4.90 | 5.00 | 6.29 | 6.33 | 4.99 | 4.15 | 4.38 | 3.74 | 4.53 | 3.55 | 3.73 | 4.55 | 6.85 |